Raymond James & Associates’s Amplify BlueStar Israel Technology ETF ITEQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,514
Closed -$249K 4047
2022
Q2
$249K Sell
5,514
-4,638
-46% -$227K ﹤0.01% 3358
2022
Q1
$568K Sell
10,152
-1,267
-11% -$70K ﹤0.01% 3000
2021
Q4
$722K Sell
11,419
-2,679
-19% -$178K ﹤0.01% 2841
2021
Q3
$930K Sell
14,098
-3,868
-22% -$264K ﹤0.01% 2630
2021
Q2
$1.26M Sell
17,966
-18,663
-51% -$1.25M ﹤0.01% 2435
2021
Q1
$2.38M Buy
36,629
+6,070
+20% +$432K ﹤0.01% 1903
2020
Q4
$2.1M Buy
30,559
+8,463
+38% +$518K ﹤0.01% 1863
2020
Q3
$1.23M Buy
22,096
+3,552
+19% +$188K ﹤0.01% 2054
2020
Q2
$874K Sell
18,544
-2,206
-11% -$95.7K ﹤0.01% 2253
2020
Q1
$742K Buy
20,750
+6,829
+49% +$289K ﹤0.01% 2170
2019
Q4
$602K Buy
13,921
+3,380
+32% +$141K ﹤0.01% 2591
2019
Q3
$420K Buy
+10,541
New +$430K ﹤0.01% 2774

Other funds holding ITEQ

Raymond James & Associates's ITEQ Position: Q3 2022 in Review

Raymond James & Associates sold out of Amplify BlueStar Israel Technology ETF (ITEQ) in Q3 2022, closing a stake of 5,514 shares — an estimated $249K sold.

Raymond James & Associates first reported a position in ITEQ in Q3 2019 and held it in 12 quarters. The position peaked at $2.38M in Q1 2021. 52 funds tracked by Wall St. Rank hold ITEQ as of Q3 2022.

  • Raymond James & Associates reported no remaining Amplify BlueStar Israel Technology ETF position as of Q3 2022 after selling out during the quarter.
  • Raymond James & Associates sold 5,514 Amplify BlueStar Israel Technology ETF shares in Q3 2022, an estimated $249K.
  • Raymond James & Associates first reported a position in Amplify BlueStar Israel Technology ETF in Q3 2019 and held it in 12 quarters.
  • Raymond James & Associates's Amplify BlueStar Israel Technology ETF position peaked at $2.38M in Q1 2021.
  • 52 funds tracked by Wall St. Rank held Amplify BlueStar Israel Technology ETF as of Q3 2022.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.